Omegaflex peri, Infusionsemulsion 1250 ml

7680656890014 CH-65689 Infusionsemulsion
Omegaflex peri, Infusionsemulsion 1250 ml
Omegaflex peri, Infusionsemulsion 1250 ml
Omegaflex peri, Infusionsemulsion 1250 ml
1 / 3
google

Article details

Package size
5 x 1250
Selling units
5
Measure
ml
Galenic form
Infusionsemulsion
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/05/2025
Summary of Product Characteristics
Français
05/05/2025
Summary of Product Characteristics
Italien
05/05/2025

Detailed composition

Substance Quantity Type Category
123C
32.0 GL Substance Wirkstoff (Principe actif)
II
20.0 G Substance Wirkstoff (Principe actif)
III
2.34 G Substance Wirkstoff (Principe actif)
I
80.0 G Substance Wirkstoff (Principe actif)
III
3.13 G Substance Wirkstoff (Principe actif)
II
25.0 G Substance Wirkstoff (Principe actif)
I
88.0 G Substance WIZUS
123C
4.56 GL Substance Wirkstoff (Principe actif)
123C
64.0 GL Substance Wirkstoff (Principe actif)
I
0.936 G Substance Wirkstoff (Principe actif)
III
2.273 G Substance Wirkstoff (Principe actif)
II
5.0 G Substance Wirkstoff (Principe actif)
123C
40.0 GL Substance Wirkstoff (Principe actif)
III
2.84 G Substance WIZUS
II
- Substance HNIDK
I
1.17 G Substance WIZUS
123C
40.0 MMOLL Substance Wirkstoff (Principe actif)
II
- Substance HNIDK
I
5.52 MG Substance Wirkstoff (Principe actif)
III
1.96 G Substance Wirkstoff (Principe actif)
III
3.51 G Substance Wirkstoff (Principe actif)
123C
24.0 MMOLL Substance Wirkstoff (Principe actif)
I
6.6 MG Substance WIZUS
II
- Substance HNIDK
II
- Substance ANTON
I
- Substance HNIDK
123C
2.4 MMOLL Substance Wirkstoff (Principe actif)
III
1.82 G Substance Wirkstoff (Principe actif)
II
- Substance HNIDK
123C
2.4 MMOLL Substance Wirkstoff (Principe actif)
III
0.57 G Substance Wirkstoff (Principe actif)
I
- Substance HNIDK
II
- Substance HNIDK
123C
0.024 MMOLL Substance Wirkstoff (Principe actif)
III
2.6 G Substance Wirkstoff (Principe actif)
III
2.7 G Substance Wirkstoff (Principe actif)
123C
38.4 MMOLL Substance Wirkstoff (Principe actif)
123C
32.0 MMOLL Substance Wirkstoff (Principe actif)
III
1.251 G Substance Wirkstoff (Principe actif)
123C
6.0 MMOLL Substance Wirkstoff (Principe actif)
III
1.69 G Substance WIZUS
III
4.85 G Substance Wirkstoff (Principe actif)
III
1.5 G Substance Wirkstoff (Principe actif)
III
3.5 G Substance Wirkstoff (Principe actif)
III
1.65 G Substance Wirkstoff (Principe actif)
III
3.4 G Substance Wirkstoff (Principe actif)
III
3.0 G Substance Wirkstoff (Principe actif)
III
0.8 G Substance Wirkstoff (Principe actif)
III
1.081 G Substance Wirkstoff (Principe actif)
III
0.328 G Substance Wirkstoff (Principe actif)
III
0.544 G Substance WIZUS
III
2.943 G Substance Wirkstoff (Principe actif)
III
0.428 G Substance Wirkstoff (Principe actif)
III
0.644 G Substance WIZUS
III
0.333 G Substance Wirkstoff (Principe actif)
III
0.441 G Substance WIZUS
III
- Substance HNIDK
III
- Substance HNIDK

Authorization holder

B. Braun Medical AG

6204 Sempach

Authorization information

Swissmedic authorization number
65689
Drug name
Omegaflex peri, Infusionsemulsion
Galenic form
EMUI
ATC Code
B05BA10
Authorization status
Z
Dispensing category
B
First authorization
07/02/2017
Authorization expiration date
31/12/9999
IT Number
07.01.2.
Domain
Human medicine
Field of application
Parenterale Ernährung

Package details

Description (FR)
OMEGAFLEX peri émuls perf 1250ml sach 5 pce
Description (DE)
OMEGAFLEX peri Inf Emuls 1250ml Btl 5 Stk
Market launch
07/02/2017
Narcotic (BTM)
No

Other package sizes (2)

None
5 x 1875 ML
GTIN: None
Not in V1
None
5 x 2500 ML
GTIN: None
Not in V1